Clinical Trial

Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida

Completed
View on ClinicalTrials.gov →
Summary
Labour is a physiological process that enables the natural delivery of fetus, placenta and membranes after the age of viability. This study compared the efficacy of valethamate bromide and hyoscine butyl bromide in reducing labour duration among primigravid women at Alex Ekwueme Federal University Teaching Hospital, Abakaliki
Trial Details
NCT Number NCT07474350
Lead Sponsor Federal Teaching Hospital Abakaliki
Conditions Labour Duration, Primigravida
Enrollment 165 participants
Start Date 2023-09-01
Primary Completion 2024-01-23 (estimated)
Study Completion 2024-01-23 (estimated)
Updated on ClinicalTrials.gov 2026-03-16